logo
Dormant algae revived after 7,000 years beneath the Baltic Sea, researchers say

Dormant algae revived after 7,000 years beneath the Baltic Sea, researchers say

Yahoo01-04-2025
Researchers have successfully revived algae that remained dormant within sediment at the bottom of the Baltic Sea for more than 7,000 years.
The tiny diatom cells have regained full biological activity despite thousands of years beneath the seafloor without light or oxygen, according to the paper, published in the ISME Journal.
MORE: Scientists discover 'legless, headless wonder' that predated the dinosaurs
The specimen was extracted from sediment cores taken from a spot nearly 800 feet deep in the Eastern Gotland Deep in 2021, according to the paper.
Many organisms, from bacteria to plankton to mammals, can go into "sleep mode," or dormancy, in order to survive periods of unfavorable environmental conditions -- switching to a state of reduced metabolic activity, according to the researchers. The dormancy often provides robust protective structures and internally stored energy reserves for the organisms.
For phytoplankton, the organisms sink to the bottom of the ocean during dormancy, and they are eventually covered by sediment over time and preserved by the lack of oxygen.
In a breakthrough experiment, researchers from the Leibniz Institute for Baltic Sea Research Warnemünde were able to practice "'resurrection ecology" to return the plankton to full viability under favorable conditions, according to Sarah Bolius, phytoplankton expert at the institute and lead author of the study. The evolutionary biology technique involves reviving dormant organisms from lake sediments to study animals as they existed at the time they were buried in the sediment.
The visible algae was able to be awakened from dormancy from nine sediment samples under favorable nutrient and light conditions, the researchers said.
MORE: What scientists learned from a well-preserved fossil of this iconic Jurassic-era species
Despite remaining dormant for several thousands of years, the phytoplankton specimens did not lose any of their "fitness" or biological performance ability, Bolius said in a statement. Even the oldest algae isolates can still actively produce oxygen, a measurement of photosynthetic performance found.
Successful resurrections of dormant organisms have rarely been documented, according to the researchers.
"This means that it is now possible to conduct 'time-jump experiments' into various stages of Baltic Sea development in the lab," Bolius said.
Dormant stages of phytoplankton extracted from the Baltic Sea can be clearly assigned to specific periods due to the "clear stratification" of the Baltic Sea sediment, Bolius said in a statement.
The diatom species Skeletonema marinoi was the only phytoplankton species revived from the samples. The species is common in the Baltic Sea and typically occurs during the spring bloom, according to the researchers.
MORE: Well-preserved remains of saber-toothed kitten found frozen in Russian tundra, researchers say
The researchers are hoping to use the findings to discover more about the environment at the time. They will compare the organisms to modern phytoplankton and also analyze other sediment components to draw conclusions about past salinity, oxygen and temperature conditions, according to the paper. The research has also shown that they can directly trace genetic changes over many millennia by analyzing living cells, rather than fossils or traces of DNA.
"Such deposits are like a time capsule containing valuable information about past ecosystems and the inhabiting biological communities, their population development and genetic changes," Bolius said.
Dormant algae revived after 7,000 years beneath the Baltic Sea, researchers say originally appeared on abcnews.go.com
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Iliamna volcano in Alaska rumbling despite being dormant for over 100 years, scientists say

time18 hours ago

Iliamna volcano in Alaska rumbling despite being dormant for over 100 years, scientists say

An Alaskan volcano that has been inactive for more than 100 years is showing signs of rumbling, according to scientists. However, there's a chance that the activity could be signs of a pending avalanche, rather than a volcanic eruption, NASA said. The Iliamna volcano, located near the Cook Inlet in southern Alaska, last erupted in 1867, but would still rumble every few years due to avalanches large enough to register on nearby seismic and infrasound instruments, according to NASA. The region has recently experienced a "flurry of shaking," according to the Alaska Volcano Observatory. On June 15, seismic activity ramped up at a "nearly continuous" rate for several hours, the observatory reported. The Operational Land Imager, a sensor aboard the Landsat 8 satellite, acquired an image of the volcano on June 10, prior to when the rumblings began. The seismic activity was similar to those caused by the initial slipping between rock and ice that preceded large avalanches on the volcano in the past, according to the AVO. Iliamna often experiences massive avalanches due to the combination of glacial ice weakened rock and volcanic heat, scientists say. Its peak is covered in glaciers, snow and ice and it sits on a base of Jurassic-era granite, according to the NPS. Since its last eruption, the volcano was recorded ejecting smoke and light ash in 1876, 1933, 1941 and 1947, according to the NPS. More reports of smoke and light ash were recorded for the late winter of 1956 or early spring of 1957, but those reports were not confirmed, the NPS said. In 1958, four columns of vapor were shooting out of vents on the eastern side of the volcano, according to the NPS. But that was the last time smoke appeared to be ejected by the volcano. Although Iliamna is remote -- located in the Chigmit Mountains within Lake Clark National Park and Preserve -- it is monitored closely be volcanologists due to its potential hazards. There are several communities within a 200-mile radius of the volcano that could be impacted in the event of an eruption, including Pedro Bay, Port Alsworth and Anchorage, according to the NPS. The AVO monitors 51 other active volcanos within the state, including the Redoubt Volcano, Iliamna's more eruptive neighbor, which is also located within the preserve. The U.S. Geological Survey currently has Iliamna at a "normal" volcano alert level.

Canaccord Genuity Lifts Atai Life Sciences N.V. (ATAI)'s Price Target To $12, Maintains Buy Rating
Canaccord Genuity Lifts Atai Life Sciences N.V. (ATAI)'s Price Target To $12, Maintains Buy Rating

Yahoo

time3 days ago

  • Yahoo

Canaccord Genuity Lifts Atai Life Sciences N.V. (ATAI)'s Price Target To $12, Maintains Buy Rating

Atai Life Sciences N.V. (NASDAQ:ATAI) is one of the 13 Best German Stocks to Invest in Now. On July 2, analysts at Canaccord Genuity lifted the stock's price target from $11 to $12, while maintaining a Buy rating for its shares. A close-up of a medical professional providing advice to a patient struggling with opioid use disorder. The adjustment followed the joint announcement by Atai Life Sciences N.V. (NASDAQ:ATAI) and Beckley Psytech Limited of encouraging results from the Phase 2b clinical trial evaluating the efficacy of a single dose of BPL-003 in patients with treatment-resistant depression (TRD). Canaccord noted the potential commercial advantage BPL-003 could enjoy after the results stated the average time to meet readiness for discharge criteria was under two hours post-dose. The analysts added that Atai Life Sciences N.V. (NASDAQ:ATAI) remains 'significantly undervalued relative to the sizes of the opportunities in the mental health indications it is targeting.' Atai Life Sciences N.V. (NASDAQ:ATAI) and Beckley Psytech Limited plan on engaging the U.S. FDA and other agencies regarding Phase 3 trial design for patients in the coming months. Atai Life Sciences N.V. (NASDAQ:ATAI) is a clinical-stage biopharmaceutical company focused on the research, development, and commercialization of mental health treatments. While we acknowledge the potential of ATAI as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: Goldman Sachs Stock Portfolio: 10 Large-Cap Stocks To Buy and 13 Best Big Name Stocks to Buy Now. Disclosure: None. Sign in to access your portfolio

Recent Agreements Set To Bolster BioNTech SE (BNTX)'s Oncology Arm
Recent Agreements Set To Bolster BioNTech SE (BNTX)'s Oncology Arm

Yahoo

time3 days ago

  • Yahoo

Recent Agreements Set To Bolster BioNTech SE (BNTX)'s Oncology Arm

BioNTech SE (NASDAQ:BNTX) is one of the 13 Best German Stocks to Invest in Now. It is a clinical-stage biotechnology company focused on immunotherapies to treat cancer and other serious diseases. A microbiologist observing a petri dish of bacteria under a microscope. On June 2, the company announced that it had agreed with Bristol Myers Squibb for the global joint development and commercialization of BioNTech SE (NASDAQ:BNTX)'s investigational bispecific antibody BNT327 for solid tumor types. Under the terms of the agreement, Bristol Myers Squibb will pay BioNTech SE (NASDAQ:BNTX) up to $11.1 billion for the partnership, including $3.5 billion in unconditional payments. The deal reflects the German company's ambition to continue a costly, long-term focus on cancer treatments, and shows that its collaboration with Pfizer for the COVID-19 vaccine was not a singular achievement. Later in the month, on June 12, BioNTech SE (NASDAQ:BNTX) announced that it would acquire CureVac for approximately $1.25 billion in shares, which is expected to further strengthen the company's research, development, and commercialization of mRNA-based cancer treatments. While we acknowledge the potential of BNTX as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: Goldman Sachs Stock Portfolio: 10 Large-Cap Stocks To Buy and 13 Best Big Name Stocks to Buy Now. Disclosure: None. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store